- Home
- SWKS vs QGEN Comparison
SWKS vs QGEN Comparison
Compare SWKS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWKS
- QGEN
- Stock Information
- Founded
- SWKS 1962
- QGEN 1986
- Country
- SWKS United States
- QGEN Netherlands
- Employees
- SWKS N/A
- QGEN N/A
- Industry
- SWKS Semiconductors
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SWKS Technology
- QGEN Health Care
- Exchange
- SWKS Nasdaq
- QGEN Nasdaq
- Market Cap
- SWKS 10.8B
- QGEN 9.1B
- IPO Year
- SWKS 1968
- QGEN 1996
- Fundamental
- Price
- SWKS $72.13
- QGEN $46.76
- Analyst Decision
- SWKS Hold
- QGEN Buy
- Analyst Count
- SWKS 20
- QGEN 7
- Target Price
- SWKS $80.33
- QGEN $49.51
- AVG Volume (30 Days)
- SWKS 3.9M
- QGEN 1.4M
- Earning Date
- SWKS 07-29-2025
- QGEN 07-30-2025
- Dividend Yield
- SWKS 3.89%
- QGEN 2.83%
- EPS Growth
- SWKS N/A
- QGEN N/A
- EPS
- SWKS 2.56
- QGEN 0.42
- Revenue
- SWKS $3,952,200,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- SWKS N/A
- QGEN $6.36
- Revenue Next Year
- SWKS N/A
- QGEN $6.18
- P/E Ratio
- SWKS $28.14
- QGEN $110.70
- Revenue Growth
- SWKS N/A
- QGEN 3.31
- 52 Week Low
- SWKS $47.93
- QGEN $37.63
- 52 Week High
- SWKS $120.86
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- SWKS 56.08
- QGEN 64.44
- Support Level
- SWKS $71.21
- QGEN $46.25
- Resistance Level
- SWKS $72.67
- QGEN $47.70
- Average True Range (ATR)
- SWKS 1.68
- QGEN 0.62
- MACD
- SWKS -0.26
- QGEN -0.00
- Stochastic Oscillator
- SWKS 54.38
- QGEN 68.56
About SWKS Skyworks Solutions Inc.
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).